---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-021526"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2022-04-26T23:59:59+00:00"
generated_at: "2026-06-26T04:43:29.443196+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Lantern Pharma board nominee Maria Maccecchini; director Leslie Kreis not standing for reelection

## Summary
- Leslie W. Kreis, Jr. will not stand for reelection at the June 8, 2022 annual meeting.
- Maria L. Maccecchini, Ph.D., CEO of Annovis Bio (ANVS), nominated to the board.
- She brings over 30 years biopharma experience in neurodegenerative disease and drug development.
- Kreis served since 2019; CEO Panna Sharma thanked him for guiding Lantern through IPO and growth.

## SEC filing metadata
- accession: 0001213900-22-021526
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2022-04-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000121390022021526/0001213900-22-021526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000121390022021526/ea158857-8k_lantern.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-021526
- JSON: https://secwatch.observer/filing/0001213900-22-021526.json
- Plain text: https://secwatch.observer/filing/0001213900-22-021526.txt

## Key facts
- Executive change
  Leslie W. Kreis, Jr. departed as Director at Lantern Pharma Inc..
  - Action: will not stand for reelection
  - Role: Director
  source text: On April 20, 2022, Leslie W. Kreis, Jr. notified Lantern Pharma Inc. (the “Company”) that he will not stand for reelection to the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1763950/000121390022021526/0001213900-22-021526-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.